Cosmetic neurotoxin compositions comprising a botulinum toxin component and methods

Details for Australian Patent Application No. 2005292595 (hide)

Owner Allergan, Inc.

Inventors First, Eric R.

Agent Davies Collison Cave

Pub. Number AU-B-2005292595

PCT Pub. Number WO2006/039014

Priority 10/957,004 01.10.04 US

Filing date 24 August 2005

Wipo publication date 13 April 2006

Acceptance publication date 10 February 2011

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 8/99 (2006.01) Cosmetics or similar toilet preparations

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61P 17/00 (2006.01) Drugs for dermatological disorders

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/039014 Priority application(s): WO2006/039014

10 February 2011 Application Accepted

  Published as AU-B-2005292595

9 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005292599-Endoscopic apparatus with integrated hemostasis device

2005292578-Foam-based fasteners